GlassScriptPhysician profile
Steven A Klein
NPI 1013137017
$1,733.89
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $229 · 2021: $385 · 2022: $235 · 2023: $347 · 2024: $223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.33 |
| Education | $205.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $548.15 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $234.95 | 2019-2023 | Prolia, Evenity |
| Abbvie INC. | $175.17 | 2019-2023 | |
| Pfizer INC. | $125.36 | 2019-2023 | |
| Millicent US INC | $114.79 | 2019-2024 | Intrarosa |
| Mayne Pharma Commercial LLC | $103.73 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $94.96 | 2021-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $59.19 | 2020-2022 | |
| Osmotica Pharmaceutical Corp. | $53.50 | 2019 | |
| Exeltis, USA INC. | $50.45 | 2019-2021 | |
| Scynexis, INC. | $49.28 | 2022 | |
| Myovant Sciences INC. | $33.20 | 2021 | |
| Evofem Biosciences, INC. | $32.86 | 2021 | |
| Lupin INC. | $27.25 | 2019-2020 | |
| Duchesnay USA Incorporated | $17.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.